NCT04325581View on ClinicalTrials.gov

Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Weight Loss
Interventions
DRUG

Liraglutide 6 MG/ML

Liraglutide in incremental dose upto maximum of 1.8 mg per day SC daily

DRUG

Placebos

Normal Saline SC daily

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT04325581 - Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients | Biotech Hunter | Biotech Hunter